MISHLANOV, V.,
KHOVAEVA, Y.,
CHUCHALIN, A.,
AISANOV, Z.,
CHERESHNEV, V.,
POBEREZHETS, V.,
VITACCA, M.,
NEVZOROVA, V.,
VIZEL, A.,
SHUBIN, I.,
NIKITIN, A.,
ZULKARNEEV, R. (2019) methodology of patient's treatment and its evaluation. This
status suggests that first of all m
LIU, Z.,
ZHANG, R.,
CHEN, X.,
YAO, P.,
YAN, T.,
LIU, W.,
YAO, J.,
ZHAO, S.,
SOKHATSKII, A.,
GAREEV, I. (2019) in the inflammatory response, chemokine activity, and
immune response. The KEGG analysis identified several pathways
KORYTINA, G.F.,
AKHMADISHINA, L.Z.,
KOCHETOVA, O.V.,
VIKTOROVA, T.V.,
AZNABAEVA, Y.G.,
ZAGIDULLIN, SH.Z. (2019) ); this association was confirmed in the subgroups differentiated by smoking
status. Markers of COPD risk were also
ATAS, A.E.,
SARAC, A.,
DIRICAN, A.,
TOPBASI, N.,
UZAR, T.,
RASTGAR, L.,
PANKINA, E.,
OZKAYA, S. (2019) pulmonary CT angiography in 45 patients (62.5%) who presented an appropriate clinical
status